A comprehensive immunohistochemical analysis of IMP2 and IMP3 in 542 cases of ovarian tumors by Kristýna Němejcová, Michaela Kendall Bártů, Romana Michálková, Jana Drozenová, Pavel Fabian, Oluwole Fadare, Jitka Hausnerová, Jan Laco, Radoslav Matěj, Gábor Méhes, Naveena Singh, Simona Stolnicu, Petr Škapa, Marián Švajdler, Ivana Stružinská, David Cibula, Roman Kocian, Sigurd F. Lax, W. Glenn McCluggage, Pavel Dundr

Get full text

Dataset on patients with Recurrent Borderline Ovarian Tumors and Table with Review of Literature on Fertility and Oncologic Outcomes of patients with Borderline Ovarian Tumors by Helmut Plett, MD, Enzo Ricciardi, MD, PhD, Philipp Harter, MD, PhD, Beyhan Ataseven, MD, PhD, Florian Heitz, MD, Sonia Prader, MD, Stephanie Schneider, MD, Sebastian Heikaus, MD, PhD, Annette Fisseler-Eckhoff, MD, PhD, Friedrich Kommoss, MD, PhD, Sigurd F. Lax, MD, PhD, Annette Staebler, MD, PhD, Alexander Traut, Andreas du Bois, MD, PhD

Get full text

A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer by Sandra Kendzia, Susanne Franke, Tarek Kröhler, Nicole Golob-Schwarzl, Caroline Schweiger, Anna M. Toeglhofer, Christina Skofler, Stefan Uranitsch, Amin El-Heliebi, Julia Fuchs, Andreas Punschart, Philipp Stiegler, Marlen Keil, Jens Hoffmann, David Henderson, Hans Lehrach, Marie-Laure Yaspo, Christoph Reinhard, Reinhold Schäfer, Ulrich Keilholz, Christian Regenbrecht, Rudolf Schicho, Peter Fickert, Sigurd F. Lax, Frank Erdmann, Marcel H. Schulz, Alexandra K. Kiemer, Johannes Haybaeck, Sonja M. Kessler

Get full text